Human skeletal muscle expresses leptin receptor mRNA, however it remains unknown whether leptin receptors (OB-R) are also expressed at the protein level. Fourteen, healthy men (age = 33.1 ± 2.0 yr, height = 175.9 ± 1.7 cm, body mass = 81.2 ± 3.8 kg, body fat = 22.5 ± 1.9%; mean ± s.e.m.) participated in this investigation. The expression of OB-R protein was determined in skeletal muscle, subcutaneous adipose tissue and hypothalamus using a polyclonal rabbit anti-human leptin receptor. Three bands with a molecular weight close to 170, 128 and 98 KDa were identified by Western blot with the anti-OB-R antibody. All three bands were identified in skeletal muscle, the 98KDa and 170KDa bands were detected in hypothalamus and the 98KDa and 128 KDa bands were detected in thigh subcutaneous adipose tissue. The 128 KDa isoform was not detected in four subjects, while in the rest its occurrence was fully explained by the presence of intermuscular adipose tissue as demonstrated using an antiperilipin A antibody. No relationship was observed between the basal concentration of leptin in serum and the 170 KDa band density. In conclusion, a long isoform of the leptin receptor with a molecular weight close to 170 KDa is expressed at the protein level in human skeletal muscle. The amount of 170 KDa protein appears to be independent of the basal concentration of leptin in serum.
Introduction.
Leptin is a 16-kDa hormone structurally related to cytokines (66) that plays a crucial role in the regulation of appetite and fat deposition (19, 38) . This hormone is primarily released by white adipose tissue and acts on brain and peripheral receptors (18, 24, 45 ) that belong to the class I type cytokine receptor family (61, 65) . There are at least six isoforms of leptin receptors (OB-Rs) generated by mRNA alternative splicing and/or proteolytic processing of the subsequent protein products (22, 33, 61) . All these receptors contain identical extracellular and transmembrane domains and differ in the length of the intracellular amino acid sequence (22, 33, 61) . The long form of the leptin receptor (OB-Rb) has an intracellular domain, highly conserved in several species, that is critical for the effects of this hormone (22, 61, 65) . Upon leptin binding, the OB-Rb is activated, leading to stimulation of the janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway, like the other class I cytokine receptors (9, 12, 61) . In the central nervous system, leptin/OB-Rb interaction leads to the activation of JAK2 by transphosphorylation and subsequent phosphorylation of tyrosine residues (Tyr985 and Tyr1138) in the cytoplasmic part of OB-Rb (11, 27) .
Expression of OB-R mRNA has also been found in non-neuronal tissues (32) such as bone, heart, liver, lung, adrenal glands, testes, spleen, small intestine, pancreatic islets, the placenta, adipose tissue and skeletal muscle (1, 10, 20, 36, 43, 48) . However, the presence of OB-R protein has not been shown in some human tissues in which mRNA for OBR has been detected such as skeletal muscle (17) , cultures of primary skeletal muscle cells (55) subcutaneous adipose tissue (51) and hypothalamus (15) .
In addition to its locomotive function, skeletal muscle accounts for the majority of the basal metabolic rate and is also the primary tissue responsible for whole body glucose and fatty acid metabolism (57) . Animal experiments have shown that leptin has physiological effects in skeletal muscle (17, 23, 37) , however, it remains unknown if human skeletal muscle is actually able to respond to circulating leptin (7) . Plasma leptin concentration is directly proportional to adipose tissue mass. Increasing fat mass results in higher levels of circulating leptin (18, 24) while reducing the body fat stores through regular exercise and/or dieting results in lower plasma leptin concentrations (28, 46, 62) . Human obesity is characterised by a high concentration of leptin in plasma associated with leptin resistance (8, 60) . Obesity also causes insulin resistance in humans (30, 44) , which has been associated with raised plasma leptin concentrations independent of body fat mass (50, 56) . Leptin resistance could be caused by a down-regulation and/or desensitisation of OB-Rs, among other mechanisms.
In this study we planned to test two hypotheses. First, that leptin receptors are expressed at the protein level in human skeletal muscle. Second, that the amount of OB-R protein expression in skeletal muscles depends on the basal concentration of leptin. To test these hypothesis we carried out Western blot analysis in protein extracts obtained from human muscle biopsies and from a human hypothalamus. The hypothalamus protein extract was used as a control to verify that any band identified as a potential OB-R in muscle is also present in the hypothalamic protein extract, since the hypothalamus is rich in OB-R protein content (53) .
To test the second hypotheses we determined if plasma leptin concentration correlates with the protein expression of OB-R in skeletal muscle.
Materials and methods.

Materials
The Complete TM protease inhibitor cocktail was obtained from Roche Diagnostics (Mannheim, Germany). The polyclonal rabbit anti-human leptin receptor that recognises the extracellular domain of human leptin receptor was obtained from Linco Research (St.
Charles, Missouri, USA). The recombinant human leptin R/Fc chimera, generated from 
Subjects
Fourteen, healthy men (age = 33.1 ± 2.0 yr, height = 175.9 ± 1.7 cm, body mass = 81.2 ± 3.8 kg, body fat = 22.5 ± 1.9%) participated in this investigation. Written informed consent was obtained from each subject after they received a full explanation about the study procedures.
The study was performed in accordance with the Helsinki Declaration of 1975, being approved by the Ethical Committee of the University of Las Palmas de Gran Canaria.
General procedures
The body composition of each subject was determined by DXA (Hologic QDR-1500, Hologic Corp., software version 7.10, Waltham, MA) as described elsewhere (5, 6, 52). On a different day, following an overnight fast a muscle biopsy was obtained from the middle portion of the vastus lateralis muscle using the Bergstrom's technique without suction, as described elsewhere (35) . The muscle specimen was cleaned to remove any visible blood, fat, or connective tissue. Then the muscle tissue was immediately frozen in liquid nitrogen, and stored at -80°C for later analysis. In some subjects a small piece of subcutaneous adipose tissue was also sampled (2-3 cm) apart from the incision using the same kind of needle, without suction to minimise the risk of contamination of the subcutaneous biopsy with blood.
Human brain material
The OB-R expression was determined in a protein extract from adult human hypothalamus by
Western blot analysis. The rationale for targeting this tissue is the high content of OB-R protein found in rodents (49) and that it has been reported expression of OB-R mRNA (both short and long isoforms) has been reported in human hypothalamus (15) . The hypothalamic extracts were prepared using unfixed brain obtained from necropsies of three cognitively normal subjects (aged 26-75 years), whose brains were extracted shortly after death (less than 10 h post-mortem) and frozen at -80 °C. The donors had no neurodegenerative disease. These procedures conformed with the rules of the Ethical Committee of the University of La Laguna in accordance with the declaration of Helsinki. Material from these brains has also been used in other studies (16) .
Protein Preparation for Western blotting
For total protein extraction from human skeletal muscle and subcutaneous adipose tissue, a piece of frozen tissue was homogenised in urea lysis buffer (6 M urea A whole blood protein extract was obtained from 10 ml of EDTA anticoagulated blood that was drawn from an antecubital vein. The blood was mixed with a hypotonic solution and after erythrocyte lysis, the pellet, containing the leukocytes, was extracted using the urea lysis buffer and procedures described above.
Electrophoresis and Western blot analysis
Proteins were solubilised in sample buffer containing 0.0625 M Tris-HCl, pH 6.8,
Equal amounts (50 µg) of each sample were electrophoresed on 7.5-10 % sodium dodecyl sulfate -polyacrylamide gel electrophoresis (SDS-PAGE) using the system of Laemmli (31) and transferred to Hybond-P membranes according to the method of Towbin et al. (63) . 
Competitive Assays for OB-R
To evaluate the specificity of the anti-OB-R antibody used in this investigation competitive assays were performed with increasing amounts of recombinant human leptin R/Fc (RH OB-R) chimera (0, 10, 100, 500 ng) pre-incubated with anti-OB-R antibody (diluted 1:2,000 in blotto blocking buffer) overnight at 4ºC. OB-R protein expression from muscular extracts was analysed by Western blot with the pre-incubation solution. Data are reported as a percentage of OB-R immunostaining values (band quenching) in presence of increasing amounts of recombinant human leptin R/Fc chimera relative to those observed for a control that was not pre-incubated with recombinant human leptin R/Fc.
Potential contamination by whole blood or subcutaneous adipose tissue
To assess if a small contamination by blood could influence the OB-R immunostainings whole human blood protein extracts were obtained from two healthy subjects and processed for Western blot analysis as described above. Skeletal muscle biopsies may be contaminated by a small amount of adipose tissue which may come from the adipose tissue accumulated between the muscle bundles and/or by subcutaneous fat tissue. Although the latter possibility µg of muscle protein extract. In the second experiment increasing amounts of muscle protein extracts were added to 10 µg of protein extract from adipose tissue. In both experiments the expression of OB-R was determined by Western blot analysis.
Leptin Assays
Serum leptin were determined by Enzyme-Linked Immunosorbent Assay (ELISA) (ELx800 Universal Microplate Reader, Bioteck Instruments Inc, Vermont, USA), using reagent kits from Diagnostic Systems Laboratories (Webster, Texas, USA) and following the manufacturer's instructions. The sensitivity of the total leptin assays was 0.05 ng/mL (4). The intra-assay coefficient variation was 3.8% and the inter-assay coefficient of variation was 4.4%.
Statistical analyses
The statistical analyses was performed using the SPSS software package (SPSS INC, Chicago, IL) version 8.0. All data is reported as mean ± standard error mean (SEM). The relationships between leptin and band densities were tested with linear regression analysis.
Calibration curves for the relationship between perilipin A band density and protein content from subcutaneous adipose tissue fat were obtained by linear regression analysis. Pearson's correlation coefficients were used to assess associations between leptin and OB-R protein expression. The sample population was ordered according to the basal leptin concentration values and then split into two groups, each composed of seven subjects. One group consisted of the subjects with the seven lowest values of plasma leptin, while the other group contained the subjects with the seven highest leptin concentrations. The band densities of the 170 KDa isoform were compared between these two groups using a Student's t-test. A statistical test was considered significant at P 0.05 level (two-tailed).
Results
Identification of OB-R in human skeletal muscle
The protein expression of the leptin receptor (OB-R) in human skeletal muscle was determined by Western blot analysis using an antibody raised against its extracellular domain.
This antibody revealed the presence of three bands in which molecular weight was approximately 170, 128 and 98 KDa ( figure 2A, D) . The 170 KDa band was detected in skeletal muscle and hypothalamus protein extracts (Figure 2A ). The other two bands migrating at 128 and 98 KDa were identified in skeletal muscle and thigh subcutaneous adipose tissue protein extracts (Figure 2A ). The 98 KDa band was also found in hypothalamus protein extracts (Figure 2A) . No immunosignal was observed in the absence of primary antibody (data not shown). The 128 KDa isoform was not detected in four subjects, implying that the level of expression was undetectable or that the 128 KDa isoform was not expressed at all in the skeletal muscle (Figure 2A ). In the latter case, the 128 KDa observed in some subjects indicated contamination by surrounding adipose tissue or adipocytes located in between the muscle fibers. In contrast the 170 and the 98 KDa isoforms were detected in all 14 subjects (Figure 2A ). 
Specificity of the antibody: competitive assays
Competitive assays with recombinant human leptin R/Fc chimera as a competitive blocker of the antigen-antibody interaction showed that the antibody was able to bind specifically to the three bands detected (Figure 3 ). This implies that the OB-R bands share a common epitope with the recombinant human leptin R/Fc chimera which contains an amino acid sequence of the extracellular domain of the human OB-R.
Contribution of adipose tissue to the OB-R band density in skeletal muscle tissue
Assuming that muscle fibers do not express perilipin A (47), the band density of perilipin A measured by immunoblotting ( Figure 1 ) and normalised by alfa-tubulin was equivalent to the presence of 1.18±0.13 micrograms of protein coming from adipose tissue in 50 µg ( Figure   2B ) of protein extract obtained from the muscle biopsies. This perilipin A band density corresponded to a level of contamination by adipose tissue protein of 2.4±0.2% in the protein extract from the muscle biopsies. By adding different amounts of protein extracts from subcutaneous adipose tissue to a 50 µg of muscle protein extract we obtained by linear regression an equation describing the impact that contamination by adipose tissue had on the muscular 170, 128 and 98 KDa band densities ( Figure 4A ). With the determination of perilipin A protein content in muscular tissue we obtained a value of potential contamination by fat which, when combined with the previous experiment, allowed us to calculate how much of the specific OB-Rs band densities could be explained by contamination of the muscle sample with subcutaneous adipose tissue. Contamination by adipose tissue could account for 89% of the 98 KDa OB-R band density and for all of the 128 KDa band density observed in the muscle protein extract. In turn, the contamination by adipose tissue had no effect on the 170 KDa density ( Figure 4A ). Adding increasing amounts of muscle protein extract to a 10 µg of subcutaneous adipose tissue protein extract resulted in a proportional increase of the three OB-R band densities ( Figure 4B ). The 170 KDa band was only detectable when 10 µg or more of muscle protein extracts were added to the adipose tissue protein extract ( Figure 4B ).
There was no sign of OB-R contamination from blood since in protein extracts from whole blood (with loads up to 100 µg of protein) OB-R was undetectable (data not shown).
Relationship between serum leptin and muscle OB-R bands
Serum leptin concentration was 15.9±2.7 ng/mL. There was no relationship between serum leptin concentration and the 170 KDa OB-R band density. There was a trend for a linear relationship between serum leptin and the 98 KDa band density (r = 0.52, P = 0.06). Despite huge differences in basal leptin concentration in serum between the group with low and high basal leptin concentrations in serum (7.9 ± 1.6 and 23.9 ± 2.9 ng/mL, respectively, P < 0.05), the 170 KDa OB-R optical density was similar (0.51 ± 0.10 and 0.47 ± 0.05, arbitrary units, respectively, P = 0.74).
Discussion
In the present study, we hypothesised that the OB-R protein should be expressed in human skeletal muscle. This was based on previous studies revealing the presence of OB-R mRNA in human skeletal muscle (17) and cultures of primary skeletal muscle cells (55) , and also upon the fact that primary skeletal muscle cells in culture respond to leptin by increasing ERK activity (55) and/or or AMPK activity and fatty acid oxidation (41, 59) . This study confirms (HUVECs) (13) . Our results also demonstrate that the density of these three bands was reduced in competitive Western blot assays performed with increasing concentrations of recombinant human leptin R/Fc quimera which contains the extracellular domain (aa residues 1-839) of OB-R. These data suggest that the antibody used in this study recognised specifically the three OB-R bands detected in skeletal muscle and that muscular tissue OB-R proteins detected with this antibody contain the extracellular domain of the human OB-R.
These results implied that human skeletal muscle expresses the long and short isoforms of the leptin receptor. However, skeletal muscle is a complex tissue and some adipose tissue (or adipocytes) may be present in between or around the muscle fibers and/or bundles (25, 29) . Only the intermuscular adipose tissue that was visible could be removed However, the important point to bear in mind is that even a "clean" skeletal muscle biopsy always contains a significant amount of adipose tissue, a fact that has been often overlooked in other studies examining the expression of OB-R mRNA (17, 34, 48) .
Solberg et al. reported the existence of a functional long isoform of the OB-R in primary skeletal muscle cells derived from human skeletal muscle biopsies (55) . To obtain these cells the authors first separated the satellite cells by dissection and successive incubations with trypsin/EDTA. Then the satellite cells were grown in culture wells where they differentiated into myoblasts and fused together leading to the formation of myotubes.
When these myotubes were exposed to leptin they responded by ERK activation, with a small increase in fatty acid oxidation. A similar stimulation of fat oxidation by leptin has also been reported in cultured myotubes derived from lean but not obese humans (59 analysis loading up to 100 µg of protein extract from blood leucocyte fraction was negative for OB-R (data not shown). This is likely due to structural and/or compositional differences between the extracellular domain of the OB-Re and that of the OB-Ra, OB-Rb and OB-Rf isoforms (1). Thus, we can rule out contamination by blood as source of OB-R immunoreactivity in our muscle samples.
The presence of a long isoform of the leptin receptor in the skeletal muscle fibers might have important implications for the understanding of the metabolic regulation of human energy metabolism, and may be critical to unravel the physiopathology of the metabolic syndrome and insulin resistance (57, 59) . The 170 KDa band could very well be the main ligand for leptin in skeletal muscle (9, 11, 12, 61) . It has also been shown that this isoform phosphorylates in response to leptin binding (8) and this phosphorylation has been linked to the activation of intracellular cascades with subsequent effects on fatty acid transport and metabolism (41, 42, 58) .
In summary, this study shows that a long isoform of the leptin receptor with a molecular weight close to 170 KDa is expressed at the protein level in human skeletal muscle.
The amount of 170 KDa protein appears to be independent of the basal concentration of leptin in serum. In addition, we describe a procedure based on the determination of perilipin A content, a protein exclusive of adipocytes, to determine the degree of adipose tissue infiltration in human muscle biopsies. The latter procedure was critical for the interpretation of our results. Adipose tissue contamination must be assessed when using rough protein extracts from skeletal muscle if the aim is to study molecules that may be also present in intermuscular adipose tissue. Future experiments with human and animal models of hypo and hyperleptinemia, and longitudinal studies in dieting and/or exercising humans, should be carried out to establish the role of this isoform of the leptin receptor in the regulation of skeletal muscle metabolism.
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